Moya Daniels

Moya Daniels has a long and impressive career in Regulatory Affairs and Clinical Operations. Starting in 2001, they were the Regulatory Affairs/Quality Assurance Manager and Quality Control/Quality Assurance Manager at Osiris Therapeutics. Moya then moved to Macrocure in 2013 as Vice President, Regulatory Affairs, Advanced Cell Therapy Products. In 2014, they joined Fate Therapeutics Inc. as Vice President Regulatory Affairs. From 2017 to 2021, they held roles at Orchard Therapeutics, SanBio, Aruvant (Company Closed Operations), and Theirtogen. In 2021, they founded Gaia Regulatory Consulting and is currently the CEO & Founder. In 2022, they will join Indapta Therapeutics as SVP, Regulatory Affairs and Clinical Operations.

Moya Daniels has a varied educational background. Moya completed a BS in Biology at Saint Augustine’s University between 1986 and 1990. Moya then went on to Ross University School of Medicine for a Masters level education in Medicine, which they completed between 1994 and 1996. Most recently, they completed a MS in Health Care Administration at the University of Maryland Global Campus in 2011.